About The Medical Condition RWJ15927

ClusterMed

Find the definition of the medical term RWJ15927. RWJ15927 defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.

RWJ15927

RWJ15927 Medical Condition Defined & Explained
RWJ15927 Medical Condition

What's The Definition Of The Medical Condition RWJ15927?

A synthetic methylprostaglandin E1 analog that reduces gastric acid secretion and enhances the gastric mucus-bicarbonate barrier. It is effective in the therapy of gastric ulcers and gives significant protection against NSAID-induced gastric mucosal damage. The drug also prevents cyclosporin A-induced damage to endocrine and exocrine pancreatic secretions. It shows a low order of acute toxicity and there is no evidence of embryotoxicity, fetotoxicity, teratogenicity, or mutagenicity in animal studies.

More Medical Conditions

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Medical Conditions Definitions Of The Day